Jason Wilson
Director/Board Member presso CytoSen Therapeutics, Inc.
Profilo
Fondatore di Platial, Inc., Jason D. Wilson è attualmente vicepresidente esecutivo delle operazioni di Reata Pharmaceuticals, Inc. È anche nel consiglio di amministrazione di CytoSen Therapeutics, Inc. In precedenza ha occupato la posizione di Vice Presidente-Finance & Controller presso Inform Diagnostics, Inc., Vice Presidente-Prodotti presso Platial, Inc. e Senior Manager-Health Sciences Group presso Ernst & Young LLP. Ha conseguito una laurea presso la Henderson State University (Arkansas) e un MBA presso la University of Central Arkansas.
Posizioni attive di Jason Wilson
Società | Posizione | Inizio |
---|---|---|
CytoSen Therapeutics, Inc.
CytoSen Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CytoSen Therapeutics, Inc. develops natural killer (NK) cell therapeutics for cancer. It offers nanoparticle processing technology which enables improved ex vivo expansion and activation of NK-cells supporting multiple high dose infusions with anti-cancer cytotoxicity. The company was founded by Stefan O. Ciurea, Dean Lee and Robert Igarashi and is headquartered in Orlando, FL. | Director/Board Member | - |
Precedenti posizioni note di Jason Wilson
Società | Posizione | Fine |
---|---|---|
Inform Diagnostics, Inc.
Inform Diagnostics, Inc. Hospital/Nursing ManagementHealth Services Inform Diagnostics, Inc. provides pathology diagnostic services. It offers subspecialty anatomic pathology in the fields of breast health, dermatology, gastroenterology, hematology, and urology. The company was founded by David D. Halbert and Harold Roe in 1996 and is headquartered in Irving, TX. | Director of Finance/CFO | 01/01/2006 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
REATA PHARMACEUTICALS, INC. | Director of Finance/CFO | 28/08/2019 |
Formazione di Jason Wilson
Henderson State University (Arkansas) | Undergraduate Degree |
University of Central Arkansas | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Inform Diagnostics, Inc.
Inform Diagnostics, Inc. Hospital/Nursing ManagementHealth Services Inform Diagnostics, Inc. provides pathology diagnostic services. It offers subspecialty anatomic pathology in the fields of breast health, dermatology, gastroenterology, hematology, and urology. The company was founded by David D. Halbert and Harold Roe in 1996 and is headquartered in Irving, TX. | Health Services |
CytoSen Therapeutics, Inc.
CytoSen Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CytoSen Therapeutics, Inc. develops natural killer (NK) cell therapeutics for cancer. It offers nanoparticle processing technology which enables improved ex vivo expansion and activation of NK-cells supporting multiple high dose infusions with anti-cancer cytotoxicity. The company was founded by Stefan O. Ciurea, Dean Lee and Robert Igarashi and is headquartered in Orlando, FL. | Commercial Services |
- Borsa valori
- Insiders
- Jason Wilson